Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.610
-0.010 (-0.62%)
At close: Sep 4, 2025, 4:00 PM
1.600
-0.010 (-0.62%)
Pre-market: Sep 5, 2025, 8:12 AM EDT
Organigram Global Market Cap
Organigram Global has a market cap or net worth of $213.51 million as of September 5, 2025. Its market cap has decreased by -0.64% in one year.
Market Cap
213.51M
Enterprise Value
240.07M
1-Year Change
-0.64%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since May 21, 2019, Organigram Global's market cap has decreased from $1.01B to $213.51M, a decrease of -78.96%. That is a compound annual growth rate of -21.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 217.10M | 24.20% |
| Dec 31, 2024 | 174.80M | 64.44% |
| Dec 29, 2023 | 106.30M | -57.67% |
| Dec 30, 2022 | 251.10M | -51.98% |
| Dec 31, 2021 | 522.90M | 151.76% |
| Dec 31, 2020 | 207.70M | -45.73% |
| Dec 31, 2019 | 382.70M | -62.29% |
| May 21, 2019 | 1.01B | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.11B |
| Johnson & Johnson | 426.93B |
| AbbVie | 375.22B |
| UnitedHealth Group | 277.48B |
| Novo Nordisk | 253.55B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.78B |